Glaxosmithkline Pharma LT
₹2,939.80▼ -56.30 (-1.88%)
GLAXO·NSE·Healthcare
Market Cap
50308.51 Cr
PE Ratio
48.08
Volume
20,052
Day High - Low
2990.10 - 2935.40
52W High-Low
3120.70 - 2088.10
₹2,939.80▼ -56.30 (-1.88%)
Market Cap50308.51 Cr
PE Ratio48.08
Volume20,052
Day High - Low2990.10 - 2935.40
52W High-Low3120.70 - 2088.10
DocStoX Score
6.8/10
Fair
Fair Value
Sign in to see
ROE
45.60%
Strong
P/E
48.08x
Expensive
Debt / Equity
0.01
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed
Price performance
NIFTY 500NIFTY MIDCAP 150
Day₹2935
₹2990
52W₹2088
₹3121
DocStoX take
Supported by risk (9.4) and quality (9.2), but held back by valuation (0.0). Risk looks strong at 9.4, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidence6.8
/10
Fair
Quality
Excellent
ROE 45.6%
Valuation
Expensive
P/E 48.1×
Growth
Steady
Revenue +5.5% 5Y CAGR
Risk
Low risk
D/E 0.01
Momentum
Strong
82% of 52-week range
At a glance
Market Cap
₹50,309 Cr
52W High / Low
₹3121 / ₹2088
Dividend Yield
1.86%
Promoter Holding
75.00%
EPS (TTM)
₹61.15
Book Value
₹134.00
Key highlights
- Capital works hard — ROCE 61%
- Strong returns on equity (46%)
- Low leverage — D/E 0.01
- Valuation is weak (0.0/10)
4 Positives1 Watchout
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore GLAXOSMITHKLINE PHARMA LT’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
GLAXOSMITHKLINE PHARMA LT peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
SUN PHARMACEUTICAL IND LDIVI S LABORATORIES LTDTORRENT PHARMACEUTICALS LAPOLLO HOSPITALS ENTER. LZYDUS LIFESCIENCES LTDCIPLA LTDLAURUS LABS LIMITEDLUPIN LIMITEDMANKIND PHARMA LIMITEDAUROBINDO PHARMA LTDMAX HEALTHCARE INS LTDDR. REDDY S LABORATORIES
Compare GLAXOSMITHKLINE PHARMA LT with peers
GLAXOSMITHKLINE PHARMA LT vs SUN PHARMACEUTICAL IND LGLAXOSMITHKLINE PHARMA LT vs DIVI S LABORATORIES LTDGLAXOSMITHKLINE PHARMA LT vs TORRENT PHARMACEUTICALS LGLAXOSMITHKLINE PHARMA LT vs APOLLO HOSPITALS ENTER. LGLAXOSMITHKLINE PHARMA LT vs ZYDUS LIFESCIENCES LTDGLAXOSMITHKLINE PHARMA LT vs CIPLA LTD
Related tools & concepts
Value GLAXOSMITHKLINE PHARMA LT with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing